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Abstract
Introduction: Idiopathic systemic vasculitis represents a group of clinical entities having non-
specific etiology with the common characteristic of acute or chronic inflammatory compromise of
the small and large vessels walls, associated with fibrinoid necrosis.
Objectives: To describe the most common inflammatory vascular diseases in a long historical
cohort of patients from San Juan de Dios Hospital located in Bogota, Colombia using two different
systems and a clinical histopathological correlation format, and to make a comparison between
them.
Methods:  We reviewed all previously ascertained cases of vasculitis confirmed by biopsy
processed between 1953 and 1990, and systematically collected data on all new cases of vasculitis
from 1991 to 1997 at the Hospital San Juan de Dios (Bogota – Colombia). The cases were classified
in accordance with the Chapel Hill Consensus criteria, and the system proposed by J.T. Lie.
Results: Of 165,556 biopsy tissue specimens obtained during this period from our hospital, 0.18%
had vasculitis, perivasculitis or vasculopathy. These included 304 histopathological biopsies from
292 patients. Cutaneous leukocytoclastic vasculitis (64 histological specimens) was the most
frequently encountered type of "primary" vasculitis followed by thromboangiitis obliterans (38
specimens), and polyarteritis nodosa (24 specimens). Vasculitis associated with connective tissue
diseases (33 specimens) and infection (20 specimens) were the main forms of secondary vasculitis,
a category that was omitted from the Chapel Hill consensus report. We found that 65.8% of our
histopathological diagnoses could not be classified according to the Chapel Hill classification, and
35.2% could not be classified according to the classification of Lie. Only 8.9% of cases remained
unclassified by our system after clinical and histological correlation.
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Conclusion: Current vasculitis classification schemes are designed for classification, rather that
diagnosis of disease and do not adequately address some common forms of inflammatory vascular
diseases, including those of infectious etiology and unusual etiology seen in clinical practice. Based
on our clinical experience, we suggest a classification outline which practitioners can use which
emphasizes correlation of the clinical picture to the histopathology findings for diagnosis and
therapy, which may promote better clinical practice and standardization for clinical trials.
Introduction
Systemic vasculitis represents a heterogeneous group of
clinical entities having non-specific etiology with the
common characteristic of acute or chronic inflammatory
compromise of the small and large vessels walls, associ-
ated with fibrinoid necrosis. Histopathological examina-
tion is the main basis for diagnosing these diseases.
Vasculitis may be primary, or associated with another dis-
eases process. Infections, hypersensibility to drugs, atrial
myxoma, solid cancers, and lymphoproliferative or other
connective tissue diseases are among the entities causing
secondary vasculitis [1-17].
Criteria have been defined for classifying the different
types of vasculitis by the American College of Rheumatol-
ogy (ACR) Vasculitis Study Committee, which however
limited itself to defining "primary" vasculitis characteris-
tics. The ACR introduced criteria for some vasculitides in
1990, and has proposed different parameters for classify-
ing each one of these entities [18-26]. Only seven types of
vasculitis are considered in the ACR scheme. These and
the classification system proposed by J. T. Lie [27] and by
Chapel Hill consensus conference [28] in 1994 are in use
today. These criteria are not designed for diagnosis of vas-
culitis, and are inadequate for clinical application, and
omit important clinical forms of vasculitis.
With few exceptions, only sporadic reports of vasculitis
are found in Latin-American literature [29-56]. Some of
the larger series include classification studies of Alarcón-
Segovia [57-59] and one cohort of patients with primary
vasculitis of the Cisterna's group in Chile [60]. The epide-
miology of the primary vasculitides is best studied in
Europe and North America [61-72]. There have been no
such studies in South America.
With this study, we describe the different types of vasculi-
tis most frequently found in the San Juan de Dios' Hospi-
tal from Bogotá, Colombia using two current
classification systems as well as our own clinical-patho-
logical correlation.
Methods
This is a descriptive study performed in two phases. All
165,556 histological specimens (129,192 between 1953
and 1990 and 36,364 between 1991 and 1997) processed
in the Universidad Nacional de Colombia's Pathology
Department (Bogotá, Colombia) were compiled. The data
from the 1953–1990 cases were obtained from medical
record review of all patients with a positive biopsy speci-
men. After 1990, cases were compiled using a standard
case report form (CRF) as patients attended consultation
in the clinical setting. All reports from each examination
were reviewed and all those with vascular inflammatory
compromise collected; 304 confirmed cases of vasculitis
were found (187 between 1953 and 1990, and 117
between 1991 and 1997). These included 187 specimens
from the 1953–1990 period and 117 from 1991–1997.
These specimens were reviewed by rheumatologists and
by members of the pathology department of a third level
university hospital from Bogotá, Colombia (Hospital San
Juan de Dios).
Results were expressed in frequencies since the total
number of patients that consulted during these years was
not available, so that an approximate calculation of inci-
dence could not be performed. Of 165,556 biopsies proc-
essed by the histopathology laboratory of our hospital,
304 specimens from 292 patients had evidence of vascular
inflammatory involvement. Once a diagnosis was made
on histopathological grounds, the cases were classified
according to the Chapel Hill [28] and J. T. Lie classifica-
tion proposal [27]. The criteria defined by the ACR [18-
26] for classifying primary vasculitis were also applied,
however these encompass only 7 types of vasculitis, and it
was necessary to expand the spectrum of vasculitis entities
according to clinical, laboratory, and histological consid-
erations. All histological studies were re-reviewed and
diagnosed according to clinical, laboratory and his-
topathological information.
Results
Of the 165,556 tissue specimens, 0.18 percent could be
assigned a diagnosis of vasculitis, perivasculitis or vascu-
lopathy (Tables 1 and 2). Three-hundred-four histopatho-
logical biopsies from 292 patients with documented
vasculitis were found during that period. More than one
sample was obtained from twelve patients, those with two
histological specimens were: six with Buerger's disease (in
one of these the diagnosis on first biopsy was not conclu-
sive); two patients with polyarteritis nodosa (in both the
initial diagnosis was inconclusive); two patients withJournal of Autoimmune Diseases 2009, 6:1 http://www.jautoimdis.com/content/6/1/1
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inconclusive results of histology, including one diagnosed
with cutaneous leukocytoclastic vasculitis and the other
with connective tissue disease vasculitis.
The average age of the patients from whom these speci-
mens were obtained was 36 years, ranging from 10 to 99.
Male/female ratio was 1:2. Most specimens corresponding
to vasculitis came from skin (64.5%), amputated extrem-
ities (11.5%) and muscle (8.2%).
Primary vasculitis was the diagnosis in the minority of our
biopsies; thirty-four percent (104 specimens) of the his-
topathological studies corresponded to primary vasculitis
according to the Chapel Hill Consensus Conference while
forty-six percent (142 specimens) revealed a primary vas-
culitis according to the system of J. T. Lie (Tables 1 and 2).
The most frequently encountered types of primary vascu-
litis were cutaneous leukocytoclastic vasculitis (64 speci-
mens), followed by thromboangiitis obliterans (38
specimens) (all of this obtained from tissue of amputated
extremities), polyarteritis nodosa (24 specimens), and
Henoch-Schönlein purpura (Tables 1, 2, 3).
Vasculitis associated with connective tissue diseases (33
specimens) was the most frequently encountered classifi-
cation among those specimens classified as secondary vas-
culitis according to the scheme proposed by J.T. Lie, while
vasculitis associated with infection was the next most
common type (20 specimens; Tables 2 and 3).
In our format of clinical-pathological correlation we
found that leukocytoclastic vasculitis was the most fre-
quent with 107 specimens, followed by lymphomono-
cytic vasculitis with 53 specimens. Only 27 specimens
(8.9%) could not be classified with our or any scheme.
Within the cases that were unable to be classified using the
system of JT Lie or the Chapel Hill proposal are the lym-
phomonocytic vasculitis (53 specimens), several cases of
granulomatous vasculitis, nodular vasculitis (19 speci-
mens) and illnesses that resemble vasculitis, including
arterial embolism (4 specimens) (Table 3).
Discussion
Vasculitis classification are diverse and employ several
organizing principles including the size of the compro-
mised vessel, whether an underlying pathoetiology is
Table 1: Classification of histological specimens with vasculitis from the San Juan de Dios Hospital, Bogotá, Colombia, 1953 – 1997, 
according to the Chapel Hill system [28]
Vasculitis diagnosis Number
N = 304
Frequencies
per 100,000 histological specimens
Percentages
groups of vasculitis subgroups of vasculitis
I. Primary vasculitis 104 62.8 34.2
A. Large vessel vasculitis 1 0.6 1
1. Giant cell (Temporal) arteritis 1 0.6
B. Medium sized vessel vasculitis 24 14.5 23.1
1. Polyarteritis nodosa 24 14.5
C. Small vessel vasculitis 79 47.7 75.9
1. Wegener's granulomatosis 3 1.8
2. Churg-Strauss syndrome 2 1.2
3. Microscopic polyangiitis 1 0.6
4. Henoch-Schönlein purpura 9 5.4
5. Cutaneous leukocytoclastic vasculitis 64 38.7
II. Not classified vasculitis 200 120.8 65.8
Total 304 183.6 100Journal of Autoimmune Diseases 2009, 6:1 http://www.jautoimdis.com/content/6/1/1
Page 4 of 10
(page number not for citation purposes)
found (primary versus secondary vasculitis); the main
type of vessel compromise (artery, vein, capillary, etc.),
the type of immune damage and others.
Attempts to classify vasculitis began with the work of Pearl
Zeek in 1952 [61] and many others have proposed their
own classification schemes [27,28,57-59,62-91]. Consid-
erations of the ACR [78], Lie [27,79-81], Churg [83,84],
and others were taken into account during development
of the Chapel Hill consensus conference criteria [28,91].
Zeek's concept of classifying vasculitis according to the
size of the comprised vessel: small, medium-or large-sized
continues to be widely used. This proposal, along with
other proposals regarding vessel size, has been adapted by
many authors who have since built upon it.
Table 2: Classification of histological specimens with vasculitis from the San Juan de Dios Hospital, Bogotá, Colombia, 1953 – 1997, 
according to the scheme of Lie [27]
Vasculitis diagnosis Number
N = 304
Frequencies
per 100,000 histological specimens
Percentages
groups of vasculitis subgroups of vasculitis
I. Primary vasculitis 142 74 46.7
A. Affecting large, medium and small sized blood 
vessels
1 0.6 0.7
1. Giant cell (Temporal) arteritis 1 0.6
B. Affecting predominantly medium and small-
sized blood vessels
29 17.5 20.4
1. Polyarteritis nodosa 24 14.5
2. Churg-Strauss syndrome 2 1.2
3. Wegener's granulomatosis 3 1.8
C. Affecting predominantly small-sized blood 
vessels
74 44.7 52.1
1. Microscopic polyangiitis 1 0.6
2. Henoch-Schönlein purpura 9 5.4
3. Cutaneous leukocytoclastic angiitis 64 38.7
D. Miscellaneous conditions 38 23 26.8
1. Buerger's disease 38 23
II. Secondary vasculitides 55 33.2 18.1
1. Infection-related vasculitis 20 12.1
2. Connective tissue disease vasculitis 33 20
3. Hypocomplementemic urticarial vasculitis 1 0.6
4. Vasculitis associated with neoplasia 1 0.6
III. Unclassified vasculitis 107 64.6 35.2
Total 304 183.6 100Journal of Autoimmune Diseases 2009, 6:1 http://www.jautoimdis.com/content/6/1/1
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Table 3: Histological specimens with vasculitis from the San Juan de Dios Hospital, Bogotá, Colombia, 1953 – 1997, according to a 
clinical-pathological correlation of vasculitis [92]
Vasculitis diagnosis Number
N = 304
Frequencies
per 100,000 histological specimens
Percentages
groups of vasculitis subgroups of vasculitis
1. Leukocytoclastic vasculitis 107 64.6 35.2
1.1. Erythema elevatum diutinum 1 0.6 0.9
1.2. Secondary to diseases 42 25.4 39.3
1.2.1. SLE 14 8.5
1.2.2. PM/DM 14 8.5
1.2.3. Diffuse/limited scleroderma 5 6.7
1.2.4. Henoch-Schönlein purpura 9 5.4
1.3 Livedoid leukocytoclastic vasculitis 5 3 4.7
1.4. Idiopathic 59 35.6 55.1
2. Lymphomonocitic's vasculitis 53 32 17.4
2.1. Schamberg's purpura 1 0,6 1.9
2.2. Chronic urticaria, associated 1 0.6 1.9
2.3. Idiopathic 51 30.8 96.2
3. Nodular vasculitis 19 11.5 3.6
3.1. Erythema nodosum 7 4.2 36.8
3.2. Granulomatous panniculitis 2 1.2 10.5
3.3. Vasculitis in panniculitis 4 2.4 21.1
3.4. Idiopathic 6 3.6 31.6
4. Granulomatous vasculitis 11 6.6 3.6
4.1. Wegener's granulomatosis 3 1.8 27.3
4.2. Churg Strauss 2 1.2 18.2
4.3. Lymphomatoid granulomatosis (lung) 1 0.6 9.1
4.4. Granuloma annulare 1 0.6 9.1
4.5. Giant cell (Temporal) arteritis 1 0.6 9.1
4.6. Idiopathic 3 1.8 27.3
5. Polyarteritis nodosa 24 14.5 7.9Journal of Autoimmune Diseases 2009, 6:1 http://www.jautoimdis.com/content/6/1/1
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Existing classification systems are incomplete and difficult
to use in the clinic, as they are not designed to be diagnos-
tic criteria, but rather are more useful in distinguishing
one type of vasculitis from another in populations of
patients for whom a diagnosis of vasculitis is established
[92]. For this reason, in 1993 we proposed a format for
ordering vasculitides based on their pathogenesis, histo-
logic features, and causal agents if known, with the intent
of improving understanding of them without proposing a
new classification scheme (Table 3). We consequently
included numerous entities with defined histology which
are not captured in existing classification schemes [93].
This provides a clinical-pathologic correlation which goes
beyond the incomplete current classification schemes
[93].
It is our opinion that the most representative, recognized
and utilized classifications in worldwide literature are
those of J.T. Lie, and Jennette and Falk et al., described at
the Chapel Hill Consensus Conference. We therefore ana-
lyzed this Colombian cohort in accordance with these two
classification schemes and compared them with our find-
ings based on clinical-pathological correlation.
In our experience, "primary" vasculitis seems to be
uncommon in Colombia [41], although it does occur,
including Takayasu's disease [42,92]. Since our review
concentrates on cases with biopsy evidence of disease, the
true frequency of primary vasculitis diagnosed on clinical,
but not histological grounds, is certainly higher. Further-
more, we observed that a significant number of our cases
could not be classified by Lie's and the Chapel Hill Con-
sensus criteria (Table 3, 4). We also encountered difficul-
ties in assigning a diagnosis of vasculitis to some of our
histological studies according to whether they were pri-
mary or secondary. Many difficulties emerged while eval-
uating these cases. It was particularly difficult to make a
diagnosis based on the ACR diagnostic criteria of classic
types, since these were created for classifying patients hav-
ing defined vasculitis and not for making a specific or
even general diagnosis in patients where other vasculitis
or vasculopathies are suspected.
5.1. Generalized 16 4.8 66.7
5.2. Cutaneous 8 9.7 33.3
6. Vasculitis like diseases 4 2.4 1.3
6.1. Arterio-embolism 4 2.4 100
7. Infection-related vasculitis 20 12.1 6.6
7.1. Mycobacterium 12 7.2 60
7.2. Bacterial infections 8 4.8 40
8. Microscopic polyangiitis 1 0.6 0.3
9. Thromboangiitis obliterans 38 23 12.5
10. Unclassified vasculitis 27 16.3 8.9
TOTAL 304 100
Table 3: Histological specimens with vasculitis from the San Juan de Dios Hospital, Bogotá, Colombia, 1953 – 1997, according to a 
clinical-pathological correlation of vasculitis [92] (Continued)
Table 4: Comparison of Two Vasculitis Classifications Schemes With a Clinical-Pathological Correlation from the San Juan de Dios 
hospital, Bogotá, Colombia, 1953 – 1997 *
Percentages
Chapel Hill Lie Clinical-pathological Correlation
Classifiable 34.2 64.8 92.1
Unclassifiable 65.8 35.2 8.9
* from 304 histological specimens with inflammatory vascular compromiseJournal of Autoimmune Diseases 2009, 6:1 http://www.jautoimdis.com/content/6/1/1
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The difficulty in applying these criteria clinically was illus-
trated in a study using chart audits to classify 198 consec-
utive patients by ACR criteria, with re-audit of patient
charts after 2–8 months to ascertain the patient's ultimate
diagnosis, Rao et al, found that vasculitis was diagnosed
in 51 (26%) patients. Thirty-eight (75%) of 51 patients
with vasculitis and 31 (21%) of 147 patients without vas-
culitis met ACR criteria for one or more types of vasculitis.
The positive predictive values for the four vasculitides
according to ACR criteria were 17% to 29% for the entire
cohort and 29% to 75% for only the patients with a final
diagnosis of vasculitis [94]. It was also difficult to obtain
samples in cases where visceral compromise or large ves-
sel involvement was present, although clearly the his-
topathologic examination continues to be the gold-
standard for diagnosis.
We have pioneered the study of vasculitis in Colombia.
The San Juan de Dios Hospital was the Colombian refer-
ence center for this type of pathology during the time of
this study, and our reports may reflect the state of these
entities in Colombia and perhaps reveal Latin-American
trends in frequency of the different types of vasculitis
occurring. Small-sized vessel vasculitis is the predominant
type of primary vasculitis.
In the Latin American literature most reports of vasculitis
are those of idiopathic types. Takayasu's arteritis in Brazil
has been reported by Sato et al's group [43], and Behçet's
disease by Heyman et al and Ferraz et al [44,46]. Kawa-
saki's disease has been reported by Saraiva et al [45], and
Lucio's phenomenon has been reported by Souza et al
[38]. Cisternas et al evaluated described their patient
cohort of "primary" vasculitis in Chile [60]. Other work
groups in Mexico have made significant contributions to
the study of vasculitis, especially that of Alarcón-Segovia.
The immuno-pathological aspects of Takayasu's arteritis
have been reported on by Vargas-Alarcon [48]. Other
studies include cases of Takayasu's arteritis by Castro,
Castanon, and Robles [49,53,56]. Henoch-Schönlein pur-
pura has been reported by Reyes-Vasquez [50], Kawasaki's
diseases in children by Vizcaino-Alarcon [52], and
Behçet's disease by Alarcon-Segovia's [55]. In Peru,
Sanchez et al [95] described 29 patients with microscopic
polyangiitis and compared them with those of Guillevin's
group [96]. The Peruvian patients had more multiple
mononeuritis, less cutaneous involvement, more benign
renal disease, and a better prognosis. There are no studies
of vasculitis epidemiology in Latin American.
Cutaneous leukocytoclastic vasculitis predominated in
our study of primary vasculitis correlating with other stud-
ies reporting this as being the most frequent type.
Thromboangiitis obliterans was more frequent before
1990 (26 specimens), probably because the national
health promotion effort from the 1980s onward against
tobacco-use could account for its diminishing frequency
since then. The difference found in primary vasculitis
between the two proposed classifications is explained
largely by the absence of Buerger's disease in the Chapel
Hill scheme. Thromboangiitis obliterans (Buerger's dis-
ease) is included as a vasculitis, understanding that it is
histopathologically distinguished from other forms of
vasculitis, having an inflammatory thrombus with rela-
tively sparse evidence of inflammation in the vessel wall.
Our study found JT Lie's classification was better adapted
to those pathologies associated with vasculitis in our insti-
tution compared to that of the Chapel Hill Consensus
Conference (Table 4). This may be due to the consensus
excluding secondary vasculitis, such as those associated
with connective tissue diseases, solid tumor, atrial
myxoma, drug- or infection-related reactions, among oth-
ers. A majority, 65.8%, of the analyzed specimens were
not classified on applying Chapel Hill consensus criteria,
while fewer remained unclassified using Lie's proposed
criteria (35.2%). When we used a correlation based on
clinical diagnosis with pathological findings, only 8,9%
of the specimens were unable to be classified.
Histopathologic examination of biopsy specimens is the
gold standard for studying vasculitis in spite of existing
limitations. Currently used classifications leave many vas-
cular entities, including some forms of vasculitis which
are thus far ill-defined, without being classified. Knowl-
edge concerning these entities is limited in Latin America,
so efforts made in studying these diseases will benefit our
patients. It is also necessary to make extra efforts towards
creating more suitable classifications in which Latin-
Americans and other countries study groups may partici-
pate.
It is likely that the ethnicity, immunogenetics, and the
socioeconomic status of patients with vasculitis, among
other factors, is different in our patients than in those
described in North American and Western European
cohorts and accounts for many of the clinical differences
seen in these different groups of patients. Consequently,
an attempt must be made to include the totality of condi-
tions with clinical and histopathological findings of vas-
culitis and even vasculopathies mimicking or closely
resembling established vasculitis conditions in such new
classification schemes to facilitate clinical diagnosis and
research.
Conclusion
Current classification criteria for vasculitis do not ade-
quately address some common forms of inflammatoryJournal of Autoimmune Diseases 2009, 6:1 http://www.jautoimdis.com/content/6/1/1
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vascular diseases, including those of infectious etiology
and unusual etiology seen in clinical practice. They are
based primarily on the vessel size, rather than on his-
topathologic clinical correlation. There are about 20
forms of primary vasculitis, some of which are not
included in the current classification schemes such as
nodular vasculitis of the skin, as well as many forms of
secondary vasculitis including those associated with neo-
plasia, infection, and medications, which are not included
in current nosology.
The importance of establishing this correlation is illus-
trated by, for example, the finding of lymphomonocytic
vasculitis which is typically associated with cutaneous vas-
culitis, often but not always related to infection, medica-
tion or collagen vascular disease, and typically has a good
prognosis. The several forms of ANCA associated vasculi-
tis have pleomorphic manifestations which demand a
critical differentiated clinical approach. Based on our clin-
ical experience, we suggest a classification outline which
practitioners can use which emphasizes correlation of the
clinical picture to the histopathology findings for diagno-
sis and therapy, which may promote better clinical prac-
tice and standardization for clinical trials.
A more complete understanding of these entities may pro-
vide a better basis for classifying them. Our study suggests
that current classification schemes for vasculitis are
incomplete [97]. They must be brought up to date [98],
and must better reflect the diagnostic process used clini-
cally. At present, physicians should use the current classi-
fication systems with the understanding that they are
incomplete, and have limited value in clinical practice
[99]. Meanwhile, we think that judicious analysis of cases
of suspected vasculitis through clinical-pathological corre-
lation will continue to be important in assessment of
patients with these diseases.
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